TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17972435

Group type: EXPERIMENTAL
Intervention: IT‐program implementation in Big‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: IT‐program implementation in Small‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Awareness of IT‐programs in Big‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Awareness of IT‐programs in Small‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Need for IT‐program in Big‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Need for IT‐program in Small‐towns
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Barriers to IT‐program adoption
Number of subjects: 1267
Study: 15860043

Group type: EXPERIMENTAL
Intervention: Tenecteplase (weight-adjusted dose)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 12375548

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.2% vaginal flushings (140 ml every 6 hours until delivery)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Ampicillin 2 g intravenously (every 6 hours until delivery)
Number of subjects: 244
Study: 9895397

Group type: EXPERIMENTAL
Intervention: Superovulation and intrauterine insemination
Number of subjects: 932

Group type: COMPARATOR
Intervention: Intrauterine insemination
Number of subjects: 932

Group type: COMPARATOR
Intervention: Superovulation and intracervical insemination
Number of subjects: 932

Group type: COMPARATOR
Intervention: Intracervical insemination
Number of subjects: 932
Study: 7493434

Group type: EXPERIMENTAL
Intervention: Single 3.15 MJ meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three 1.05 MJ meals given 30 min apart
Number of subjects: 0
Study: 1724166

Group type: EXPERIMENTAL
Intervention: MK886 (oral leukotriene biosynthesis inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7071293

Group type: EXPERIMENTAL
Intervention: Selective attention task (counting electrical stimuli to one of four fingers)
Number of subjects: 16
Study: 31217318

Group type: EXPERIMENTAL
Intervention: Viewing online e‐cigarette advertisements
Number of subjects: 964
Study: 29605629

Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI rest‐dipyridamole scintigraphy in patients with DM (Dp)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 99mTc‐MIBI rest‐dipyridamole scintigraphy in patients without DM (NDp)
Number of subjects: 24
Study: 26765419

Group type: EXPERIMENTAL
Intervention: Pilates exercise program (14 weeks, thrice per week)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Social program only (control group)
Number of subjects: 38
Study: 24121009

Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Goldmann tonometer
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Noncontact tonometer
Number of subjects: 106
Study: 22028719

Group type: EXPERIMENTAL
Intervention: Burch Colposuspension (BC) with abdominal POP repair (group A)
Number of subjects: 47

Group type: COMPARATOR
Intervention: POP repair alone without any anti‐incontinence procedure (group B)
Number of subjects: 47
Study: 19491286

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 1000
Study: 17766739

Group type: EXPERIMENTAL
Intervention: IV NTG (initial dose of 0.05 microg.kg(‐1).min(‐1), followed by 0.1 microg.kg(‐1).min(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15240604

Group type: EXPERIMENTAL
Intervention: Thyroidectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withdrawal from T(4) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No transient therapy with T(3)
Number of subjects: 0
Study: 12097994

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream (Elidel)
Number of subjects: 0
Study: 11489708

Group type: EXPERIMENTAL
Intervention: Preoperative MRI with pelvic phased-array coil
Number of subjects: 176
Study: 9623263

Group type: EXPERIMENTAL
Intervention: Diffractive multifocal lens
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refractive multifocal lens
Number of subjects: 50
Study: 7936174

Group type: EXPERIMENTAL
Intervention: Gadodiamide injection at 0.1 mmol/kg body weight
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Gadodiamide injection at 0.3 mmol/kg body weight
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Gadodiamide injection (both doses)
Number of subjects: 78
Study: 3337574

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (Hibiclens) - showering both evening and morning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (Hibiclens) - showering evening only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Povidone-iodine (Betadine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lotion soap (Safe 'N Sure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorhexidine gluconate (Hibiclens)
Number of subjects: 0
Study: 1493935

Group type: EXPERIMENTAL
Intervention: Low-dose AraC (2 x 10 mg/m2 subcutaneously days 1‐14) plus GM-CSF (2 x 150 micrograms protein/day subcutaneously)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 82
Study: 835531

Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 450

Group type: COMPARATOR
Intervention: Sodium chloride
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Boric acid-sodium borate solution
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Low-birth-weight infants
Number of subjects: 450
Study: 31733045

Group type: EXPERIMENTAL
Intervention: Podiatry intervention (3 visits, foot orthoses, exercise, manual therapy, advice)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual GP care (1 visit, medication advice/prescription, same advice as podiatry group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study: 30791102

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks (q2w)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study: 30312162

Group type: EXPERIMENTAL
Intervention: Acupuncture with standard-of-care pain treatment
Number of subjects: 425

Group type: COMPARATOR
Intervention: Standard-of-care treatment only
Number of subjects: 425
Study: 27415153

Group type: EXPERIMENTAL
Intervention: Locally produced, cereal-based, ready-to-use supplementary food for five months
Number of subjects: 500

Group type: COMPARATOR
Intervention: Well-nourished controls
Number of subjects: 500
Study: 24217275

Group type: EXPERIMENTAL
Intervention: Intensive exercise training (IG)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual care treatment (CG)
Number of subjects: 148
Study: 21604065

Group type: EXPERIMENTAL
Intervention: Audio Computer-Assisted Self-Interview (ACASI)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Face-to-Face (FTF) interview
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: ACASI
Number of subjects: 274

Group type: COMPARATOR
Intervention: FTF
Number of subjects: 274
Study: 20096179

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Burch colposuspension (CS)
Number of subjects: 49
Study: 17704031

Group type: EXPERIMENTAL
Intervention: Individual counseling program (INT)
Number of subjects: 233
Study: 15863117

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer trials at 118 W in tops and drops and at 300+/‐82.4 W in top handlebar positions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer trials
Number of subjects: 0
Study: 12092923

Group type: EXPERIMENTAL
Intervention: HIV/AIDS behavioral change intervention
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Material assistance
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Trial acceptance
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sensitive mobilization and ongoing communication
Number of subjects: 58
Study: 10445535

Group type: EXPERIMENTAL
Intervention: Serial IgG antibody determinations
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Parallel IgG antibody determinations
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Cut-off for H. pylori eradication
Number of subjects: 83
Study: 7758262

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 2179511

Group type: EXPERIMENTAL
Intervention: Ultrasonic instruments
Number of subjects: 31

Group type: COMPARATOR
Intervention: Hand instruments
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both instruments
Number of subjects: 31
Study: 465432

Group type: EXPERIMENTAL
Intervention: Iron fortification of food providing 10 mg elemental Fe/child per day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (5 mg) mixed in one meal
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (3.3 mg) given with each of three meals over 2 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ferrous ascorbate (test dose)
Number of subjects: 24
Study: 30859741

Group type: EXPERIMENTAL
Intervention: Combined in-office whitening (6% hydrogen peroxide) + at-home whitening (16% carbamide peroxide for 2 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 29096672

Group type: EXPERIMENTAL
Intervention: Yoga (90-min session weekly for 8 weeks)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Stretching and resistance exercises (60-min session weekly for 8 weeks)
Number of subjects: 126
Study: 24978836

Group type: EXPERIMENTAL
Intervention: Repeated sprints in hypoxia (RSH; FIO2 = 14.3%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Repeated sprints in normoxia (RSN; FIO2 = 21.0%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: RSH
Number of subjects: 16

Group type: COMPARATOR
Intervention: RSN
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both RSH and RSN
Number of subjects: 16
Study: 24268212

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14000
Study: 21301766

Group type: EXPERIMENTAL
Intervention: Acaricides and environmental anti house dust mite (HDM) measures
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Hypersensitivity to Dermatophagoides pteronyssinus and D. farinae
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Hypersensitivity to HDM
Number of subjects: 98
Study: 19772596

Group type: EXPERIMENTAL
Intervention: Structured weekly SMS messaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care support mechanisms
Number of subjects: 0
Study: 17963859

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCs) initiation
Number of subjects: 757

Group type: COMPARATOR
Intervention: Expected rate for U.S. women aged 15‐44
Number of subjects: 757
Study: 15020159

Group type: EXPERIMENTAL
Intervention: Titanium plates and Ti-6Al-4V screws
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (Osprovit) grafts
Number of subjects: 0
Study: 12057729

Group type: EXPERIMENTAL
Intervention: Bravelle s.c.
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Bravelle i.m.
Number of subjects: 177

Group type: COMPARATOR
Intervention: Follistim s.c.
Number of subjects: 177
Study: 9467443

Group type: EXPERIMENTAL
Intervention: Nonmechanical excimer laser trephination
Number of subjects: 52

Group type: COMPARATOR
Intervention: Mechanical trephination
Number of subjects: 52
Study: 8534077

Group type: EXPERIMENTAL
Intervention: Humorous audiotape for 20 minutes
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tranquil music audiotape for 20 minutes
Number of subjects: 46

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 46
Study: 2617244

Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg i.v.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 338392

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine 10 mg
Number of subjects: 0
Study: 28735272

Group type: EXPERIMENTAL
Intervention: Perceived low nicotine cigarettes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived moderate nicotine cigarettes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived high/very high nicotine cigarettes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower perceived risk of developing other cancers and heart disease
Number of subjects: 0
Study: 27217321

Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 25
Study: 24231633

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Generalized physical activity
Number of subjects: 531

Group type: COMPARATOR
Intervention: Control with no intervention
Number of subjects: 531
Study: 22284315

Group type: EXPERIMENTAL
Intervention: PCA with tramadol (1.0 mg/kg loading dose, 10 mg metoclopramide, 0.3 mg/kg/mL every 5 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: PCA with remifentanil (placebo 100 mL 0.9% normal saline, 0.4 μg/kg/mL every two minutes)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 22254070

Group type: EXPERIMENTAL
Intervention: Annual feedback on calcium intake and strategies to improve intake
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Baseline calcium intake assessment
Number of subjects: 2000
Study: 17313719

Group type: EXPERIMENTAL
Intervention: Nambour FFQ
Number of subjects: 43
Study: 16285948

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (17 to 23 mg/kg body weight per day)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 11929950

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy with sequentially added progestins (HRTsp)
Number of subjects: 655

Group type: COMPARATOR
Intervention: Hormone replacement therapy with continuously added progestins (HRTcp)
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: HRTsp ever users
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Low-potency estrogens (oral)
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Low-potency estrogens (vaginal)
Number of subjects: 655
Study: 9485239

Group type: EXPERIMENTAL
Intervention: Minimally invasive coronary artery bypass grafting
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional coronary artery bypass grafting with cardiopulmonary bypass
Number of subjects: 62
Study: 7638806

Group type: EXPERIMENTAL
Intervention: SmartMist device at medium/early setting (medium flow, early cumulative inspired volume)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SmartMist device at slow/early setting (slow flow, early cumulative inspired volume)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SmartMist device at fast/late setting (fast flow, late cumulative inspired volume)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SmartMist device at medium/early setting
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SmartMist device at slow/early setting
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All modes of inhalation studied
Number of subjects: 9
Study: 2572036

Group type: EXPERIMENTAL
Intervention: Broxaterol (oral route, total dose 1.675 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Broxaterol (inhaled route, total dose 1.5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Salbutamol (oral route, total dose 26 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Salbutamol (inhaled route, total dose 1.5 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Broxaterol (oral route)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Broxaterol (inhaled route)
Number of subjects: 8
Study: 319271

Group type: EXPERIMENTAL
Intervention: ticrynafen
Number of subjects: 20

Group type: COMPARATOR
Intervention: hydrochlorothiazide
Number of subjects: 20
Study: 31843335

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus androgen deprivation therapy (AAP + ADT)
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Placebo plus androgen deprivation therapy (PBO + ADT)
Number of subjects: 1199
Study: 28121978

Group type: EXPERIMENTAL
Intervention: Vibrating Cold Device (VCD)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Topical Lidocaine cream (TL)
Number of subjects: 224
Study: 27561376

Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (applied from 3 days before to 7 days after surgery)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no rivastigmine patch)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Rivastigmine patch
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 25326135

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Bromide dilution
Number of subjects: 71

Group type: COMPARATOR
Intervention: Dual energy X‐ray absorptiometry (DXA)
Number of subjects: 71
Study: 23242542

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 676

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 676
Study: 21364458

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 18397386

Group type: COMPARATOR
Intervention: Ribavirin 800 mg/day
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Ribavirin 1000/1200 mg/day
Number of subjects: 891
Study: 17159017

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy lifestyle (HL) control group
Number of subjects: 48
Study: 12669750

Group type: EXPERIMENTAL
Intervention: Response selection during go trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response selection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preparation time in go trials
Number of subjects: 0
Study: 11127213

Group type: EXPERIMENTAL
Intervention: HRT (2 mg of estradiol valerate and 1 mg of cyproterone acetate with or without vitamin D3, 100-300 IU + 93 mg calcium as lactate per day)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Non-HRT (93 mg of calcium alone or in combination with vitamin D3, 100-300 IU/day)
Number of subjects: 331
Study: 9192993

Group type: EXPERIMENTAL
Intervention: Prophylactic intracavitary treatment with interferon alpha 2b (IFN‐alpha‐2b)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated patients and healthy control subjects
Number of subjects: 0
Study: 7948351

Group type: EXPERIMENTAL
Intervention: 75% lipid/25% glucose regimen
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose alone
Number of subjects: 14
Study: 3295446

Group type: EXPERIMENTAL
Intervention: MRI at 0.15 T
Number of subjects: 157

Group type: COMPARATOR
Intervention: Sham-imaged
Number of subjects: 157

Group type: COMPARATOR
Intervention: Nonimaged control
Number of subjects: 157
Study: 29086103

Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP) - 12-week individual, home-delivered ADHD parent training program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) - 12-week group-based parent training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study: 24747996

Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 503

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 503

Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 503
Study: 23140031

Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rectal Balloon Training (RBT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (PFMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (RBT)
Number of subjects: 28
Study: 20547275

Group type: EXPERIMENTAL
Intervention: Enhanced intervention: brochure, FOBT plus telephone counseling (n=768)
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Basic intervention: culturally tailored brochure plus FOBT kit (n=765)
Number of subjects: 1358

Group type: COMPARATOR
Intervention: Usual care (n=256)
Number of subjects: 1358
Study: 18537189

Group type: EXPERIMENTAL
Intervention: Entecavir 1 mg
Number of subjects: 286

Group type: COMPARATOR
Intervention: Lamivudine 100 mg
Number of subjects: 286
Study: 15643531

Group type: EXPERIMENTAL
Intervention: Fluid ingestion during 3‐h cycling exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: No fluid ingestion during 3‐h cycling exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: No exercise and no fluid ingestion
Number of subjects: 16
Study: 12860920

Group type: EXPERIMENTAL
Intervention: ICD recipients
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Controlled breathing frequency of 0.10 Hz
Number of subjects: 85

Group type: COMPARATOR
Intervention: Young healthy individuals
Number of subjects: 85
Study: 10382913

Group type: EXPERIMENTAL
Intervention: Lower limb surgery (hip and knee release, aponeurectomy of the iliotibial band, Achilles tendon lengthening)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Lower limb surgery
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group (natural history, non-operated DMD patients)
Number of subjects: 213
Study: 7720152

Group type: EXPERIMENTAL
Intervention: Low-dose midazolam (0.03 mg.kg-1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High-dose midazolam (0.06 mg.kg-1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Midazolam (both doses)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 2252879

Group type: EXPERIMENTAL
Intervention: Large loop excision of the transformation zone (LLETZ)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Carbon dioxide laser vaporization
Number of subjects: 199
Study: 6103906

Group type: EXPERIMENTAL
Intervention: Fenoterol hydrobromide, 1 mg/ml, nasal spray (204 to 576 microgram)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31835994

Group type: EXPERIMENTAL
Intervention: Posterior sciatic nerve block (group P)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Anterior sciatic nerve block (group A)
Number of subjects: 58